On the Impact of Common Sweetening Agents on Glucose Regulation, Cognitive Functioning and Gut Microbiota
- Conditions
- Healthy Subjects
- Interventions
- Other: saccharinOther: SucroseOther: Stevia glycosides
- Registration Number
- NCT02580110
- Lead Sponsor
- Lund University
- Brief Summary
The study intention is to investigate, in healthy humans, effects of 3 commonly used sweeteners on cardiometabolic risk markers, cognitive functions, and influences on gut microbiota composition.
- Detailed Description
Healthy subjects will be included in a crossover study with the purpose to investigate effects of 3 commonly used sweeteners on cardiometabolic risk markers, cognitive functions, and influences on gut microbiota composition. The subjects will consume each test product for 14 days in a random order, separated by at least a two-week washout period. On the last day in each intervention period, i.e. at day fifteen, the last test portion will be consumed together with a standardized evening meal at 9.00 pm. Thereafter the subjects are fasting until arriving to the experimental unit. Upon arrival, test variables in blood will be determined at fasting and repeatedly for 3h postprandial a standardised breakfast served approximately at 8.00 am. Cognitive performance will be determined in the postprandial period with tests evaluating working memory capacity, selective attention, psychomotor reaction time, and executive functions. After each intervention period, faecal samples will be collected for characterization of gut microflora.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 39
- healthy subjects
- blood glucose <6.1
- BMI <28
- age between 40-70 years
- normal diet
- fluent in Swedish language (due to the structure of the cognitive tests).
- diabetes
- cognitive decline (not able to cope with the cognitive tests)
- metabolic syndrome
- gastro-intestinal disorders
- antibiotics or probiotics during the study period
- smookers
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description saccharin saccharin 14 days intervention with daily intake of a beverage (1000ml) including 0.216g saccharin. sucrose Sucrose 14 days intervention with daily intake of a beverage (1000 ml) including 66g sucrose. stevia glycosides Stevia glycosides 14 days intervention with daily intake of a beverage (1000ml) including 0.220 g stevia glycosides.
- Primary Outcome Measures
Name Time Method Incremental area under the curve (iAUC) (Glucose tolerance) predose (standardised breakfast), 0, 15, 30, 45, 60, 90, 120, 150, and 180 min post dose. The iAUC are determined after a standardized breakfast based on white wheat bread (50g available starch). The breakfast was commenced at time=0 and consumed within 10-12 min.
Incremental area under the curve (iAUC) (insulin sensitivity). predose, 0 (fasting), 15, 30, 45, 60, 90, 120, 150, and 180 min post-dose. The iAUC are determined after a standardized breakfast based on white wheat bread (50g available starch). The breakfast was commenced at time=0 and consumed within 10-12 min.
Working memory capacity 160 min Working memory capacity determined with an oral working memory test composed of short sentences that can be semantically meaningful or not. 3-5 sentences are read to the subject. After each sentence the subject immediately has to reply if the sentence is semantically meaningful or not. After the set of 3-5 sentences the subjects have to recall the first noun in each of the sentences. One test is composed of 12 set with (3-5) sentences.
Glut microbiota composition baseline and after 14 days intervention faecal samples are collected at baseline prior to the study and after each 14 day intervention period
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Food for Health Science Centre, Medicon Village, Lund University
🇸🇪Lund, Sweden